These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17577060)

  • 21. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
    Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
    Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.
    Baines SD; Chilton CH; Crowther GS; Todhunter SL; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2013 Aug; 68(8):1842-9. PubMed ID: 23557928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.
    Shim JK; Johnson S; Samore MH; Bliss DZ; Gerding DN
    Lancet; 1998 Feb; 351(9103):633-6. PubMed ID: 9500319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species.
    Naaber P; Smidt I; Štšepetova J; Brilene T; Annuk H; Mikelsaar M
    J Med Microbiol; 2004 Jun; 53(Pt 6):551-554. PubMed ID: 15150337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.
    Rea MC; Sit CS; Clayton E; O'Connor PM; Whittal RM; Zheng J; Vederas JC; Ross RP; Hill C
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9352-7. PubMed ID: 20435915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
    BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antimicrobial profile and clinical evidence of fidaxomicin (Dafclir
    Takeda S; Miki T
    Nihon Yakurigaku Zasshi; 2019; 154(4):217-229. PubMed ID: 31597902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.
    Rea MC; Dobson A; O'Sullivan O; Crispie F; Fouhy F; Cotter PD; Shanahan F; Kiely B; Hill C; Ross RP
    Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4639-44. PubMed ID: 20616009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis.
    Klostermann K; Crispie F; Flynn J; Meaney WJ; Paul Ross R; Hill C
    J Dairy Res; 2010 May; 77(2):231-8. PubMed ID: 19785910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile.
    Alam MZ; Wu X; Mascio C; Chesnel L; Hurdle JG
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5165-70. PubMed ID: 26055381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of DS-2969b and comparator antimicrobial agents against Clostridioides (Clostridium) difficile, methicillin-resistant Staphylococcus aureus, and other anaerobic bacteria.
    Tyrrell KL; Citron DM; Merriam CV; Leoncio E; Goldstein EJC
    Anaerobe; 2018 Dec; 54():39-41. PubMed ID: 30096588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces.
    Lee YJ; Yu WK; Heo TR
    Int J Antimicrob Agents; 2003 Apr; 21(4):340-6. PubMed ID: 12672580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
    Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
    Hecht DW; Galang MA; Sambol SP; Osmolski JR; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2716-9. PubMed ID: 17517836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibilities of Clostridium difficile isolated in Japan.
    Kunishima H; Chiba J; Saito M; Honda Y; Kaku M
    J Infect Chemother; 2013 Apr; 19(2):360-2. PubMed ID: 23338015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, genotype and antimicrobial resistance of Clostridium difficile isolates from healthy pets in Eastern China.
    Wei Y; Sun M; Zhang Y; Gao J; Kong F; Liu D; Yu H; Du J; Tang R
    BMC Infect Dis; 2019 Jan; 19(1):46. PubMed ID: 30634930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q.
    Li M; Yoneyama F; Toshimitsu N; Zendo T; Nakayama J; Sonomoto K
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3897-902. PubMed ID: 23733459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.